Integrated Filing (Financial) for the quarter ended 30th June, 2025.

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

SUMICHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹629.95

prior close

₹639.55

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.0%+0.3% vs market

Pesticides & Agrochemicals peers, median of 25sector+0.6%+0.8% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.8 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.5

15m

+0.9

30m

+3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.0+0.3+0.6+0.8

Next day

+0.1+0.7-0.5-0.8+1.0

-4.3-0.6-3.7-2.1-2.2

-6.5-0.7-5.8-2.8-3.7

-8.7-1.9-6.8-5.9-2.9

-7.4-1.5-5.9-5.7-1.7

-5.4-0.8-4.6-7.0+1.6

15d

-10.3-0.7-9.6-7.5-2.8

-7.6+0.0-7.6-8.3+0.7

-14.3+1.0-15.3-12.6-1.7

-20.7+2.7-23.4-19.2-1.5

UpDownMarket · Nifty Smallcap 250Sector · Pesticides & Agrochemicals peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sumitomo Chemical India reported strong Q1 FY26 results, with standalone revenue from operations rising about 26% year-on-year to Rs 1,048.07 crore from Rs 831.78 crore in Q1 FY25. Standalone profit after tax grew around 40% to Rs 179.81 crore (vs Rs 128.39 crore), pushing EPS to Rs 3.60 (not annualised) from Rs 2.57. Consolidated results were similar, with revenue at Rs 1,056.78 crore and PAT at Rs 178.10 crore, showing comparable growth. The company noted its business is seasonal and depends on monsoon conditions, and flagged the ongoing Delhi High Court hearing on the 2022 Glyphosate usage notification as a key risk to watch. BSR & Co. LLP issued an unmodified limited review report on both standalone and consolidated results.

Likely market impact

A strong quarter with over 25% revenue growth and 40% PAT growth signals healthy operating momentum and margin expansion for shareholders. The unresolved Glyphosate regulatory matter remains a key overhang to monitor but is currently stayed by the court.